In:
Biomarkers in Medicine, Future Medicine Ltd, Vol. 4, No. 5 ( 2010-10), p. 723-729
Abstract:
Therapeutic development in Parkinson’s disease is hampered by the paucity of well-validated biomarkers that can assist with diagnosis and/or tracking the progression of the disease. Since its inception, the Michael J Fox Foundation for Parkinson’s Research has invested heavily in biomarker research and continues to prioritize discovery and development efforts. This article summarizes the history and evolution of the Michael J Fox Foundation’s role in supporting biomarker research and lays out the current challenges in successfully developing markers that can be used to test therapies, while also providing a vision of future funding efforts in Parkinson’s disease biomarkers.
Type of Medium:
Online Resource
ISSN:
1752-0363
,
1752-0371
Language:
English
Publisher:
Future Medicine Ltd
Publication Date:
2010
Permalink
